Purification is a critical step in drug manufacturing

Posted: February 28, 2018

API Manufacturing and Pharmaceutical Manufacturing

Dr. Rajesh Shukla, Vice President Research and Development at PCI Synthesis Talks about Purification during the Scale-up process.

Related posts:

How to Know when to Toss your Prescription Drug or Refrigerate it
7 Criteria in selecting a CMO
The 7 Key Steps in Medical Polymer Synthesis
How to Control Impurities during API drug manufacturing
5 Points to Consider when Evaluating your CMO's Analytical Capabilities

About the Author

Ed Price CEO of PCI Synthesis
Ed is the President and CEO of PCI Synthesis (PCI), he serves as a co-chair of the New England CRO/CMO Council and sits on the Industrial Advisory Board for the Department of Chemical Engineering at UMass, Amherst. Ed is also a long standing member of the American Chemical Society and advises the Bulk Pharmaceutical Task Force of the Society of Chemical Manufacturer’s and Affiliates (SOCMA).

Do you have questions? Talk to Ed.